These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35723966)

  • 1. Comparative effect of seven prophylactic locks to prevent biofilm biomass and viability in intravenous catheters.
    Austin PD; Stapleton P; Elia M
    J Antimicrob Chemother; 2022 Jul; 77(8):2191-2198. PubMed ID: 35723966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of locking solutions on conditioning biofilm formation in tunnelled haemodialysis catheters and inflammatory response activation.
    Jiménez Hernández M; Soriano A; Filella X; Calvo M; Coll E; Rebled JM; Poch E; Graterol F; Compte MT; Maduell F; Fontsere N
    J Vasc Access; 2021 May; 22(3):370-379. PubMed ID: 32691665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Antimicrobial Durability and Anti-Biofilm Effects in Urinary Catheters Against
    Kart D; Kustimur AS; Sağıroğlu M; Kalkancı A
    Balkan Med J; 2017 Dec; 34(6):546-552. PubMed ID: 29215338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
    Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
    Trials; 2018 May; 19(1):264. PubMed ID: 29720244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces.
    Shanks RM; Sargent JL; Martinez RM; Graber ML; O'Toole GA
    Nephrol Dial Transplant; 2006 Aug; 21(8):2247-55. PubMed ID: 16627606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of a 30% ethanol/4% trisodium citrate locking solution in preventing biofilm formation by organisms causing haemodialysis catheter-related infections.
    Takla TA; Zelenitsky SA; Vercaigne LM
    J Antimicrob Chemother; 2008 Nov; 62(5):1024-6. PubMed ID: 18641034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ML8-X10 (a prototype oil-in-water micro-emulsion based on a novel free fatty acid), taurolidine/citrate/heparin and vancomycin/heparin antimicrobial lock solutions in the eradication of biofilm-producing staphylococci from central venous catheters.
    Luther MK; Mermel LA; LaPlante KL
    J Antimicrob Chemother; 2014 Dec; 69(12):3263-7. PubMed ID: 25096074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Assessment of the Antimicrobial Efficacy of Optimized Nitroglycerin-Citrate-Ethanol as a Nonantibiotic, Antimicrobial Catheter Lock Solution for Prevention of Central Line-Associated Bloodstream Infections.
    Reitzel RA; Rosenblatt J; Hirsh-Ginsberg C; Murray K; Chaftari AM; Hachem R; Raad I
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5175-81. PubMed ID: 27297475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel synergistic antibiofilm combinations for salvage of infected catheters.
    Venkatesh M; Rong L; Raad I; Versalovic J
    J Med Microbiol; 2009 Jul; 58(Pt 7):936-944. PubMed ID: 19502361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis.
    Curtin JJ; Donlan RM
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1268-75. PubMed ID: 16569839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of linezolid and vancomycin lock solutions with and without heparin against biofilm-producing bacteria.
    Luther MK; Mermel LA; LaPlante KL
    Am J Health Syst Pharm; 2017 May; 74(9):e193-e201. PubMed ID: 28438824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    Zhao Y; Li Z; Zhang L; Yang J; Yang Y; Tang Y; Fu P
    Am J Kidney Dis; 2014 Mar; 63(3):479-90. PubMed ID: 24125729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of biofilm formation with trisodium citrate in haemodialysis catheters: a randomized controlled trial.
    Bosma JW; Siegert CE; Peerbooms PG; Weijmer MC
    Nephrol Dial Transplant; 2010 Apr; 25(4):1213-7. PubMed ID: 19948873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of telavancin and vancomycin lock solutions in eradication of biofilm-producing staphylococci and enterococci from central venous catheters.
    Luther MK; Mermel LA; LaPlante KL
    Am J Health Syst Pharm; 2016 Mar; 73(5):315-21. PubMed ID: 26896504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparin.
    Handrup MM; Fuursted K; Funch P; Møller JK; Schrøder H
    APMIS; 2012 Oct; 120(10):794-801. PubMed ID: 22958287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EDTA and Taurolidine Affect Pseudomonas aeruginosa Virulence
    Colombari B; Alfano G; Gamberini C; Cappelli G; Blasi E
    Microbiol Spectr; 2021 Dec; 9(3):e0104721. PubMed ID: 34787464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiocidal effects of various taurolidine containing catheter lock solutions.
    Olthof ED; Nijland R; Gülich AF; Wanten GJ
    Clin Nutr; 2015 Apr; 34(2):309-14. PubMed ID: 24861410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies.
    Dümichen MJ; Seeger K; Lode HN; Kühl JS; Ebell W; Degenhardt P; Singer M; Geffers C; Querfeld U
    J Hosp Infect; 2012 Apr; 80(4):304-9. PubMed ID: 22342714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ethanol/trisodium citrate lock on microorganisms causing hemodialysis catheter-related infections.
    Takla TA; Zelenitsky SA; Vercaigne LM
    J Vasc Access; 2007; 8(4):262-7. PubMed ID: 18161672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based criteria for the choice and the clinical use of the most appropriate lock solutions for central venous catheters (excluding dialysis catheters): a GAVeCeLT consensus.
    Pittiruti M; Bertoglio S; Scoppettuolo G; Biffi R; Lamperti M; Dal Molin A; Panocchia N; Petrosillo N; Venditti M; Rigo C; DeLutio E
    J Vasc Access; 2016 Nov; 17(6):453-464. PubMed ID: 27516141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.